Kolexia
Laurent Camille
Anatomie et cytologie
Institut Universitaire du Cancer Toulouse Oncopole
Toulouse, France
275 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Lymphome folliculaire Maladie de Hodgkin Mastocytose Lymphome B diffus à grandes cellules Lymphome malin non hodgkinien Leucémie chronique lymphocytaire à cellules B Lymphome à grandes cellules anaplasiques

Industries

Roche
9 collaboration(s)
Dernière en 2023
Eusa Pharma
3 collaboration(s)
Dernière en 2022
KEPHREN PUBLISHING
3 collaboration(s)
Dernière en 2023
KEPHREN
2 collaboration(s)
Dernière en 2022

Dernières activités

Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)
Essai Clinique (Roche)   13 mars 2024
Cell crosstalk within lymphoma tumor microenvironment: follicular lymphoma as a paradigm.
Blood   14 décembre 2023
Glofitamab Monotherapy in Patients with Non-Hodgkin B-Cell Lymphoma after Failing CAR T-Cell Infusion: Primary Analysis of the Bicar Study, a Phase II Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Impact of Brentuximab Vedotin in Patients with Breast Implant-Associated Anaplastic Large Cell Lymphoma with Capsule Infiltration Requiring Chemotherapy
65th ASH Annual Meeting Abstracts   02 novembre 2023
CD20low/CD68high a Promising Microenvironnement Profile Identifying Classical Hodgkin Lymphoma Patients with Poor Outcome a Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
A Single Cell Atlas of Diffuse Large B Cell Lymphomas Reveals Distinct Cellular States Predictive of Outcomes
65th ASH Annual Meeting Abstracts   02 novembre 2023
Identification of MYC-Driven High-Grade B-Cell Lymphoma Using Deep Learning-Based Whole Slide Image Analysis
65th ASH Annual Meeting Abstracts   02 novembre 2023
Tazemetostat in Combination with R-CHOP in Patients with High-Risk, Frontline Follicular Lymphoma (Epi-RCHOP): A Phase II Study from the Lysa
65th ASH Annual Meeting Abstracts   02 novembre 2023
Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine.
Journal for immunotherapy of cancer   31 octobre 2023
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Nature medicine   31 octobre 2023